nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—NT5C2—seminal vesicle—testicular cancer	0.0182	0.0891	CbGeAlD
Ribavirin—IMPDH1—seminal vesicle—testicular cancer	0.0148	0.0723	CbGeAlD
Ribavirin—ENPP1—female gonad—testicular cancer	0.0146	0.0716	CbGeAlD
Ribavirin—NT5C2—gonad—testicular cancer	0.0131	0.0644	CbGeAlD
Ribavirin—ENPP1—testis—testicular cancer	0.013	0.0635	CbGeAlD
Ribavirin—SLC28A3—female gonad—testicular cancer	0.0128	0.0629	CbGeAlD
Ribavirin—ADK—seminal vesicle—testicular cancer	0.0116	0.057	CbGeAlD
Ribavirin—NT5C2—female gonad—testicular cancer	0.0107	0.0523	CbGeAlD
Ribavirin—NT5C2—testis—testicular cancer	0.00947	0.0464	CbGeAlD
Ribavirin—ENPP1—lymph node—testicular cancer	0.00939	0.046	CbGeAlD
Ribavirin—IMPDH1—female gonad—testicular cancer	0.00866	0.0425	CbGeAlD
Ribavirin—ADK—gonad—testicular cancer	0.0084	0.0412	CbGeAlD
Ribavirin—IMPDH1—testis—testicular cancer	0.00768	0.0377	CbGeAlD
Ribavirin—SLC29A1—gonad—testicular cancer	0.00716	0.0351	CbGeAlD
Ribavirin—NT5C2—lymph node—testicular cancer	0.00686	0.0336	CbGeAlD
Ribavirin—ADK—female gonad—testicular cancer	0.00683	0.0335	CbGeAlD
Ribavirin—ADK—testis—testicular cancer	0.00606	0.0297	CbGeAlD
Ribavirin—SLC29A1—female gonad—testicular cancer	0.00582	0.0285	CbGeAlD
Ribavirin—IMPDH1—lymph node—testicular cancer	0.00557	0.0273	CbGeAlD
Ribavirin—SLC29A1—testis—testicular cancer	0.00516	0.0253	CbGeAlD
Ribavirin—ADK—lymph node—testicular cancer	0.00439	0.0215	CbGeAlD
Ribavirin—SLC29A1—lymph node—testicular cancer	0.00374	0.0183	CbGeAlD
Ribavirin—Hypoaesthesia—Epirubicin—testicular cancer	0.000295	0.000371	CcSEcCtD
Ribavirin—Asthenia—Cisplatin—testicular cancer	0.000295	0.00037	CcSEcCtD
Ribavirin—Pharyngitis—Epirubicin—testicular cancer	0.000295	0.00037	CcSEcCtD
Ribavirin—Cardiac disorder—Methotrexate—testicular cancer	0.000295	0.00037	CcSEcCtD
Ribavirin—Urinary tract disorder—Epirubicin—testicular cancer	0.000293	0.000368	CcSEcCtD
Ribavirin—Oedema peripheral—Epirubicin—testicular cancer	0.000293	0.000368	CcSEcCtD
Ribavirin—Connective tissue disorder—Epirubicin—testicular cancer	0.000292	0.000367	CcSEcCtD
Ribavirin—Urethral disorder—Epirubicin—testicular cancer	0.000291	0.000366	CcSEcCtD
Ribavirin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00029	0.000364	CcSEcCtD
Ribavirin—Epistaxis—Doxorubicin—testicular cancer	0.000289	0.000363	CcSEcCtD
Ribavirin—Angiopathy—Methotrexate—testicular cancer	0.000288	0.000362	CcSEcCtD
Ribavirin—Sinusitis—Doxorubicin—testicular cancer	0.000287	0.000361	CcSEcCtD
Ribavirin—Immune system disorder—Methotrexate—testicular cancer	0.000287	0.00036	CcSEcCtD
Ribavirin—Visual impairment—Epirubicin—testicular cancer	0.000286	0.00036	CcSEcCtD
Ribavirin—Mediastinal disorder—Methotrexate—testicular cancer	0.000286	0.000359	CcSEcCtD
Ribavirin—Chills—Methotrexate—testicular cancer	0.000285	0.000358	CcSEcCtD
Ribavirin—Nausea—Ifosfamide—testicular cancer	0.000283	0.000356	CcSEcCtD
Ribavirin—Diarrhoea—Cisplatin—testicular cancer	0.000281	0.000353	CcSEcCtD
Ribavirin—Erythema multiforme—Epirubicin—testicular cancer	0.000281	0.000353	CcSEcCtD
Ribavirin—Alopecia—Methotrexate—testicular cancer	0.00028	0.000352	CcSEcCtD
Ribavirin—Bradycardia—Doxorubicin—testicular cancer	0.00028	0.000351	CcSEcCtD
Ribavirin—Mental disorder—Methotrexate—testicular cancer	0.000278	0.000349	CcSEcCtD
Ribavirin—Eye disorder—Epirubicin—testicular cancer	0.000278	0.000349	CcSEcCtD
Ribavirin—Hypersensitivity—Etoposide—testicular cancer	0.000277	0.000348	CcSEcCtD
Ribavirin—Tinnitus—Epirubicin—testicular cancer	0.000277	0.000348	CcSEcCtD
Ribavirin—Malnutrition—Methotrexate—testicular cancer	0.000276	0.000347	CcSEcCtD
Ribavirin—Erythema—Methotrexate—testicular cancer	0.000276	0.000347	CcSEcCtD
Ribavirin—Haemoglobin—Doxorubicin—testicular cancer	0.000276	0.000347	CcSEcCtD
Ribavirin—Flushing—Epirubicin—testicular cancer	0.000276	0.000346	CcSEcCtD
Ribavirin—Cardiac disorder—Epirubicin—testicular cancer	0.000276	0.000346	CcSEcCtD
Ribavirin—Rhinitis—Doxorubicin—testicular cancer	0.000275	0.000346	CcSEcCtD
Ribavirin—Hepatitis—Doxorubicin—testicular cancer	0.000275	0.000345	CcSEcCtD
Ribavirin—Haemorrhage—Doxorubicin—testicular cancer	0.000275	0.000345	CcSEcCtD
Ribavirin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000273	0.000343	CcSEcCtD
Ribavirin—Pharyngitis—Doxorubicin—testicular cancer	0.000273	0.000343	CcSEcCtD
Ribavirin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000271	0.000341	CcSEcCtD
Ribavirin—Oedema peripheral—Doxorubicin—testicular cancer	0.000271	0.00034	CcSEcCtD
Ribavirin—Dysgeusia—Methotrexate—testicular cancer	0.000271	0.00034	CcSEcCtD
Ribavirin—Asthenia—Etoposide—testicular cancer	0.00027	0.000339	CcSEcCtD
Ribavirin—Connective tissue disorder—Doxorubicin—testicular cancer	0.00027	0.000339	CcSEcCtD
Ribavirin—Angiopathy—Epirubicin—testicular cancer	0.000269	0.000338	CcSEcCtD
Ribavirin—Urethral disorder—Doxorubicin—testicular cancer	0.000269	0.000338	CcSEcCtD
Ribavirin—Immune system disorder—Epirubicin—testicular cancer	0.000268	0.000337	CcSEcCtD
Ribavirin—Mediastinal disorder—Epirubicin—testicular cancer	0.000268	0.000336	CcSEcCtD
Ribavirin—Back pain—Methotrexate—testicular cancer	0.000267	0.000336	CcSEcCtD
Ribavirin—Chills—Epirubicin—testicular cancer	0.000266	0.000335	CcSEcCtD
Ribavirin—Pruritus—Etoposide—testicular cancer	0.000266	0.000335	CcSEcCtD
Ribavirin—Arrhythmia—Epirubicin—testicular cancer	0.000265	0.000333	CcSEcCtD
Ribavirin—Visual impairment—Doxorubicin—testicular cancer	0.000265	0.000333	CcSEcCtD
Ribavirin—Alopecia—Epirubicin—testicular cancer	0.000262	0.00033	CcSEcCtD
Ribavirin—Vomiting—Cisplatin—testicular cancer	0.000261	0.000328	CcSEcCtD
Ribavirin—Vision blurred—Methotrexate—testicular cancer	0.00026	0.000327	CcSEcCtD
Ribavirin—Mental disorder—Epirubicin—testicular cancer	0.00026	0.000327	CcSEcCtD
Ribavirin—Erythema multiforme—Doxorubicin—testicular cancer	0.00026	0.000326	CcSEcCtD
Ribavirin—Rash—Cisplatin—testicular cancer	0.000259	0.000325	CcSEcCtD
Ribavirin—Dermatitis—Cisplatin—testicular cancer	0.000259	0.000325	CcSEcCtD
Ribavirin—Erythema—Epirubicin—testicular cancer	0.000259	0.000325	CcSEcCtD
Ribavirin—Malnutrition—Epirubicin—testicular cancer	0.000259	0.000325	CcSEcCtD
Ribavirin—Diarrhoea—Etoposide—testicular cancer	0.000258	0.000324	CcSEcCtD
Ribavirin—Eye disorder—Doxorubicin—testicular cancer	0.000257	0.000323	CcSEcCtD
Ribavirin—Ill-defined disorder—Methotrexate—testicular cancer	0.000256	0.000322	CcSEcCtD
Ribavirin—Tinnitus—Doxorubicin—testicular cancer	0.000256	0.000322	CcSEcCtD
Ribavirin—Anaemia—Methotrexate—testicular cancer	0.000255	0.000321	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—testicular cancer	0.000255	0.00032	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—testicular cancer	0.000255	0.00032	CcSEcCtD
Ribavirin—Flatulence—Epirubicin—testicular cancer	0.000255	0.00032	CcSEcCtD
Ribavirin—Tension—Epirubicin—testicular cancer	0.000254	0.000319	CcSEcCtD
Ribavirin—Dysgeusia—Epirubicin—testicular cancer	0.000253	0.000318	CcSEcCtD
Ribavirin—Nervousness—Epirubicin—testicular cancer	0.000251	0.000315	CcSEcCtD
Ribavirin—Back pain—Epirubicin—testicular cancer	0.00025	0.000314	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—testicular cancer	0.000249	0.000313	CcSEcCtD
Ribavirin—Malaise—Methotrexate—testicular cancer	0.000249	0.000313	CcSEcCtD
Ribavirin—Dizziness—Etoposide—testicular cancer	0.000249	0.000313	CcSEcCtD
Ribavirin—Muscle spasms—Epirubicin—testicular cancer	0.000249	0.000312	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—testicular cancer	0.000248	0.000312	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—testicular cancer	0.000248	0.000312	CcSEcCtD
Ribavirin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000248	0.000311	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—testicular cancer	0.000247	0.000311	CcSEcCtD
Ribavirin—Chills—Doxorubicin—testicular cancer	0.000247	0.00031	CcSEcCtD
Ribavirin—Arrhythmia—Doxorubicin—testicular cancer	0.000245	0.000308	CcSEcCtD
Ribavirin—Nausea—Cisplatin—testicular cancer	0.000244	0.000307	CcSEcCtD
Ribavirin—Vision blurred—Epirubicin—testicular cancer	0.000244	0.000306	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—testicular cancer	0.000243	0.000305	CcSEcCtD
Ribavirin—Cough—Methotrexate—testicular cancer	0.000241	0.000303	CcSEcCtD
Ribavirin—Mental disorder—Doxorubicin—testicular cancer	0.000241	0.000302	CcSEcCtD
Ribavirin—Ill-defined disorder—Epirubicin—testicular cancer	0.00024	0.000301	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—testicular cancer	0.000239	0.000301	CcSEcCtD
Ribavirin—Vomiting—Etoposide—testicular cancer	0.000239	0.000301	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—testicular cancer	0.000239	0.000301	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—testicular cancer	0.000239	0.000301	CcSEcCtD
Ribavirin—Anaemia—Epirubicin—testicular cancer	0.000239	0.0003	CcSEcCtD
Ribavirin—Agitation—Epirubicin—testicular cancer	0.000238	0.000298	CcSEcCtD
Ribavirin—Rash—Etoposide—testicular cancer	0.000237	0.000298	CcSEcCtD
Ribavirin—Dermatitis—Etoposide—testicular cancer	0.000237	0.000298	CcSEcCtD
Ribavirin—Headache—Etoposide—testicular cancer	0.000236	0.000296	CcSEcCtD
Ribavirin—Flatulence—Doxorubicin—testicular cancer	0.000236	0.000296	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—testicular cancer	0.000235	0.000295	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—testicular cancer	0.000235	0.000295	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—testicular cancer	0.000235	0.000295	CcSEcCtD
Ribavirin—Tension—Doxorubicin—testicular cancer	0.000235	0.000295	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—testicular cancer	0.000234	0.000294	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000234	0.000293	CcSEcCtD
Ribavirin—Malaise—Epirubicin—testicular cancer	0.000233	0.000293	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—testicular cancer	0.000232	0.000292	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—testicular cancer	0.000232	0.000292	CcSEcCtD
Ribavirin—Vertigo—Epirubicin—testicular cancer	0.000232	0.000292	CcSEcCtD
Ribavirin—Syncope—Epirubicin—testicular cancer	0.000232	0.000291	CcSEcCtD
Ribavirin—Leukopenia—Epirubicin—testicular cancer	0.000231	0.000291	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—testicular cancer	0.000231	0.000291	CcSEcCtD
Ribavirin—Muscle spasms—Doxorubicin—testicular cancer	0.00023	0.000289	CcSEcCtD
Ribavirin—Palpitations—Epirubicin—testicular cancer	0.000228	0.000287	CcSEcCtD
Ribavirin—Confusional state—Methotrexate—testicular cancer	0.000227	0.000286	CcSEcCtD
Ribavirin—Loss of consciousness—Epirubicin—testicular cancer	0.000227	0.000285	CcSEcCtD
Ribavirin—Cough—Epirubicin—testicular cancer	0.000226	0.000283	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—testicular cancer	0.000225	0.000283	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—testicular cancer	0.000225	0.000283	CcSEcCtD
Ribavirin—Convulsion—Epirubicin—testicular cancer	0.000224	0.000281	CcSEcCtD
Ribavirin—Nausea—Etoposide—testicular cancer	0.000224	0.000281	CcSEcCtD
Ribavirin—Hypertension—Epirubicin—testicular cancer	0.000223	0.00028	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000222	0.000279	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—testicular cancer	0.000221	0.000278	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—testicular cancer	0.000221	0.000278	CcSEcCtD
Ribavirin—Thrombocytopenia—Methotrexate—testicular cancer	0.000221	0.000277	CcSEcCtD
Ribavirin—Myalgia—Epirubicin—testicular cancer	0.00022	0.000276	CcSEcCtD
Ribavirin—Arthralgia—Epirubicin—testicular cancer	0.00022	0.000276	CcSEcCtD
Ribavirin—Chest pain—Epirubicin—testicular cancer	0.00022	0.000276	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—testicular cancer	0.00022	0.000276	CcSEcCtD
Ribavirin—Anxiety—Epirubicin—testicular cancer	0.000219	0.000276	CcSEcCtD
Ribavirin—Skin disorder—Methotrexate—testicular cancer	0.000219	0.000275	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000219	0.000275	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—testicular cancer	0.000218	0.000274	CcSEcCtD
Ribavirin—Discomfort—Epirubicin—testicular cancer	0.000217	0.000273	CcSEcCtD
Ribavirin—Malaise—Doxorubicin—testicular cancer	0.000216	0.000271	CcSEcCtD
Ribavirin—Dry mouth—Epirubicin—testicular cancer	0.000215	0.00027	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—testicular cancer	0.000215	0.00027	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—testicular cancer	0.000215	0.00027	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—testicular cancer	0.000215	0.000269	CcSEcCtD
Ribavirin—Leukopenia—Doxorubicin—testicular cancer	0.000214	0.000269	CcSEcCtD
Ribavirin—Confusional state—Epirubicin—testicular cancer	0.000213	0.000267	CcSEcCtD
Ribavirin—Palpitations—Doxorubicin—testicular cancer	0.000211	0.000266	CcSEcCtD
Ribavirin—Anaphylactic shock—Epirubicin—testicular cancer	0.000211	0.000265	CcSEcCtD
Ribavirin—Oedema—Epirubicin—testicular cancer	0.000211	0.000265	CcSEcCtD
Ribavirin—Hypotension—Methotrexate—testicular cancer	0.000211	0.000265	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—testicular cancer	0.00021	0.000264	CcSEcCtD
Ribavirin—Cough—Doxorubicin—testicular cancer	0.000209	0.000262	CcSEcCtD
Ribavirin—Shock—Epirubicin—testicular cancer	0.000208	0.000261	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—testicular cancer	0.000207	0.00026	CcSEcCtD
Ribavirin—Nervous system disorder—Epirubicin—testicular cancer	0.000207	0.00026	CcSEcCtD
Ribavirin—Thrombocytopenia—Epirubicin—testicular cancer	0.000207	0.00026	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—testicular cancer	0.000207	0.000259	CcSEcCtD
Ribavirin—Tachycardia—Epirubicin—testicular cancer	0.000206	0.000259	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000205	0.000258	CcSEcCtD
Ribavirin—Skin disorder—Epirubicin—testicular cancer	0.000205	0.000257	CcSEcCtD
Ribavirin—Hyperhidrosis—Epirubicin—testicular cancer	0.000204	0.000256	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—testicular cancer	0.000204	0.000256	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—testicular cancer	0.000204	0.000256	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—testicular cancer	0.000204	0.000256	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—testicular cancer	0.000204	0.000256	CcSEcCtD
Ribavirin—Anxiety—Doxorubicin—testicular cancer	0.000203	0.000255	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—testicular cancer	0.000202	0.000254	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000202	0.000254	CcSEcCtD
Ribavirin—Discomfort—Doxorubicin—testicular cancer	0.000201	0.000253	CcSEcCtD
Ribavirin—Anorexia—Epirubicin—testicular cancer	0.000201	0.000253	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—testicular cancer	0.000201	0.000253	CcSEcCtD
Ribavirin—Somnolence—Methotrexate—testicular cancer	0.0002	0.000252	CcSEcCtD
Ribavirin—Dry mouth—Doxorubicin—testicular cancer	0.000199	0.00025	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—testicular cancer	0.000198	0.000249	CcSEcCtD
Ribavirin—Hypotension—Epirubicin—testicular cancer	0.000197	0.000248	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—testicular cancer	0.000197	0.000247	CcSEcCtD
Ribavirin—Decreased appetite—Methotrexate—testicular cancer	0.000196	0.000246	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—testicular cancer	0.000195	0.000245	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000195	0.000245	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000195	0.000245	CcSEcCtD
Ribavirin—Fatigue—Methotrexate—testicular cancer	0.000194	0.000244	CcSEcCtD
Ribavirin—Pain—Methotrexate—testicular cancer	0.000193	0.000242	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000192	0.000241	CcSEcCtD
Ribavirin—Shock—Doxorubicin—testicular cancer	0.000192	0.000241	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—testicular cancer	0.000191	0.000241	CcSEcCtD
Ribavirin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000191	0.00024	CcSEcCtD
Ribavirin—Insomnia—Epirubicin—testicular cancer	0.000191	0.00024	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—testicular cancer	0.000191	0.000239	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—testicular cancer	0.00019	0.000238	CcSEcCtD
Ribavirin—Paraesthesia—Epirubicin—testicular cancer	0.000189	0.000238	CcSEcCtD
Ribavirin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000189	0.000237	CcSEcCtD
Ribavirin—Dyspnoea—Epirubicin—testicular cancer	0.000188	0.000236	CcSEcCtD
Ribavirin—Somnolence—Epirubicin—testicular cancer	0.000188	0.000236	CcSEcCtD
Ribavirin—Anorexia—Doxorubicin—testicular cancer	0.000186	0.000234	CcSEcCtD
Ribavirin—Feeling abnormal—Methotrexate—testicular cancer	0.000186	0.000233	CcSEcCtD
Ribavirin—Dyspepsia—Epirubicin—testicular cancer	0.000186	0.000233	CcSEcCtD
Ribavirin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000184	0.000232	CcSEcCtD
Ribavirin—Decreased appetite—Epirubicin—testicular cancer	0.000183	0.00023	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—testicular cancer	0.000182	0.000229	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000182	0.000229	CcSEcCtD
Ribavirin—Fatigue—Epirubicin—testicular cancer	0.000182	0.000229	CcSEcCtD
Ribavirin—Pain—Epirubicin—testicular cancer	0.00018	0.000227	CcSEcCtD
Ribavirin—Constipation—Epirubicin—testicular cancer	0.00018	0.000227	CcSEcCtD
Ribavirin—Urticaria—Methotrexate—testicular cancer	0.000179	0.000225	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—testicular cancer	0.000178	0.000224	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—testicular cancer	0.000178	0.000224	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000178	0.000223	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—testicular cancer	0.000177	0.000222	CcSEcCtD
Ribavirin—Paraesthesia—Doxorubicin—testicular cancer	0.000175	0.00022	CcSEcCtD
Ribavirin—Dyspnoea—Doxorubicin—testicular cancer	0.000174	0.000219	CcSEcCtD
Ribavirin—Feeling abnormal—Epirubicin—testicular cancer	0.000174	0.000218	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—testicular cancer	0.000174	0.000218	CcSEcCtD
Ribavirin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000173	0.000217	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—testicular cancer	0.000172	0.000216	CcSEcCtD
Ribavirin—Decreased appetite—Doxorubicin—testicular cancer	0.00017	0.000213	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000169	0.000212	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—testicular cancer	0.000168	0.000211	CcSEcCtD
Ribavirin—Urticaria—Epirubicin—testicular cancer	0.000168	0.000211	CcSEcCtD
Ribavirin—Constipation—Doxorubicin—testicular cancer	0.000167	0.00021	CcSEcCtD
Ribavirin—Pain—Doxorubicin—testicular cancer	0.000167	0.00021	CcSEcCtD
Ribavirin—Body temperature increased—Epirubicin—testicular cancer	0.000167	0.00021	CcSEcCtD
Ribavirin—Abdominal pain—Epirubicin—testicular cancer	0.000167	0.00021	CcSEcCtD
Ribavirin—Hypersensitivity—Methotrexate—testicular cancer	0.000166	0.000209	CcSEcCtD
Ribavirin—Asthenia—Methotrexate—testicular cancer	0.000162	0.000203	CcSEcCtD
Ribavirin—Feeling abnormal—Doxorubicin—testicular cancer	0.000161	0.000202	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00016	0.000201	CcSEcCtD
Ribavirin—Pruritus—Methotrexate—testicular cancer	0.00016	0.0002	CcSEcCtD
Ribavirin—Hypersensitivity—Epirubicin—testicular cancer	0.000155	0.000195	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—testicular cancer	0.000155	0.000195	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—testicular cancer	0.000154	0.000194	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—testicular cancer	0.000154	0.000194	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—testicular cancer	0.000154	0.000194	CcSEcCtD
Ribavirin—Asthenia—Epirubicin—testicular cancer	0.000151	0.00019	CcSEcCtD
Ribavirin—Pruritus—Epirubicin—testicular cancer	0.000149	0.000188	CcSEcCtD
Ribavirin—Dizziness—Methotrexate—testicular cancer	0.000149	0.000187	CcSEcCtD
Ribavirin—Diarrhoea—Epirubicin—testicular cancer	0.000144	0.000181	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—testicular cancer	0.000144	0.000181	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—testicular cancer	0.000143	0.00018	CcSEcCtD
Ribavirin—Rash—Methotrexate—testicular cancer	0.000142	0.000179	CcSEcCtD
Ribavirin—Dermatitis—Methotrexate—testicular cancer	0.000142	0.000178	CcSEcCtD
Ribavirin—Headache—Methotrexate—testicular cancer	0.000141	0.000177	CcSEcCtD
Ribavirin—Asthenia—Doxorubicin—testicular cancer	0.00014	0.000176	CcSEcCtD
Ribavirin—Dizziness—Epirubicin—testicular cancer	0.00014	0.000175	CcSEcCtD
Ribavirin—Pruritus—Doxorubicin—testicular cancer	0.000138	0.000174	CcSEcCtD
Ribavirin—Vomiting—Epirubicin—testicular cancer	0.000134	0.000169	CcSEcCtD
Ribavirin—Nausea—Methotrexate—testicular cancer	0.000134	0.000168	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—testicular cancer	0.000134	0.000168	CcSEcCtD
Ribavirin—Rash—Epirubicin—testicular cancer	0.000133	0.000167	CcSEcCtD
Ribavirin—Dermatitis—Epirubicin—testicular cancer	0.000133	0.000167	CcSEcCtD
Ribavirin—Headache—Epirubicin—testicular cancer	0.000132	0.000166	CcSEcCtD
Ribavirin—Dizziness—Doxorubicin—testicular cancer	0.000129	0.000162	CcSEcCtD
Ribavirin—Nausea—Epirubicin—testicular cancer	0.000125	0.000157	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—testicular cancer	0.000124	0.000156	CcSEcCtD
Ribavirin—Rash—Doxorubicin—testicular cancer	0.000123	0.000155	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—testicular cancer	0.000123	0.000154	CcSEcCtD
Ribavirin—Headache—Doxorubicin—testicular cancer	0.000122	0.000154	CcSEcCtD
Ribavirin—Nausea—Doxorubicin—testicular cancer	0.000116	0.000146	CcSEcCtD
